Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    19797133 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Procalcitonin Use in Pneumonia Patients in the Critical Care Setting
Condition: Pneumonia
Intervention: Other: Use of procalcitonin as biomarker to guide therapy
2 Recruiting Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON)
Condition: Ventilator-Associated Pneumonia
Interventions: Drug: 8 days of effective antibiotic treatment;   Drug: 15 days of effective antibiotic treatment

Study has passed its completion date and status has not been verified in more than two years.